Your browser doesn't support javascript.
loading
Management of preterm giant sacrococcygeal teratoma (GSCT) with an excellent outcome.
Gangadharan, Meera; Panda, Sanjeet; Almond, P Stephen; Agrawal, Vaidehi; Bhandari, Angelina; Koska, A Jay.
Afiliação
  • Gangadharan M; Department of Anesthesiology, Driscoll Children's Hospital, Corpus Christi, TX, USA meera.gangadharan@dchstx.org.
  • Panda S; Department of Pediatrics, Driscoll Children's Hospital, Corpus Christi, TX, USA.
  • Almond PS; Department of Surgery, Driscoll Children's Hospital, Corpus Christi, TX, USA.
  • Agrawal V; Department of Surgery, Driscoll Children's Hospital, Corpus Christi, TX, USA.
  • Bhandari A; Department of Anesthesiology, Driscoll Children's Hospital, Corpus Christi, TX, USA.
  • Koska AJ; Department of Anesthesiology, Driscoll Children's Hospital, Corpus Christi, TX, USA.
J Surg Case Rep ; 2014(12)2014 Dec 04.
Article em En | MEDLINE | ID: mdl-25480837
Infants born with a giant sacrococcygeal teratoma (GSCT; >10 cm) have high mortality. Risk factors for mortality include increased tumor vascularity, high cardiac output, rapid growth, diagnosis before 20-week gestation, delivery before 30-week gestation, hydrops, low birth weight, Apgar less than 7 at 5 min and polyhydramnios. We present the case of a 28-week infant born with a GSCT (15 × 12 × 16 cm) and all of these risk factors.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article